Get all your news in one place.
100’s of premium titles.
One app.
Start reading
One app.
Get all your news in one place.
100’s of premium titles. One news app.
The Latest Breaking News on After US approval, Japan OKs its first Alzheimer's drug. Leqembi was developed by Eisai and Biogen
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
Get all your
news in one place.
news in one place.
100’s of premium titles.
One news app.
One news app.
People
From analysis to the latest developments in health,
read the most diverse news in one place.
read the most diverse news in one place.
Organisations
NHS
17,712 stories
Roll Call
4,269 stories
FDA
4,119 stories
NHS England
1,081 stories
Live Science
570 stories
Eli Lilly
523 stories
CMS
271 stories
Biogen
258 stories
Lilly
238 stories
the Food and Drug Administration
96 stories
the University of Edinburgh
96 stories
Eisai
90 stories
Queen Mary University of London
53 stories
the Alzheimer Association
25 stories
Leqembi
24 stories
The University of Adelaide
23 stories
the University of Aberdeen
17 stories
Aduhelm
15 stories
Read news from The Economist, FT, and more,
with one subscription
with one subscription
Topics